Carcinogenicity and Modification of the Carcinogenic Response by bha, Bht, and Other Antioxidants

References

• Deichmann W. B., Gables C., Clemmer F. J. J., Rakoczy R., Bianchine J. Toxicity of ditertiarybutylmethylphenol. Arch. Ind. Health 1955; 11: 93
   PubMedGoogle Scholar
• Hodge H. C., Fassett D. W., Mayard E. A., Downs W. L., Coye R. D. Chronic feeding studies of butylated hydroxyanisole in dogs. Toxicol. Appl. Pharmacol. 1964; 6: 512
   PubMed Web of Science ®Google Scholar
• Hodge H. C., Maynard E. A., Down W. L., Ashton J. K., Selerno L. L. Tests on mice for evaluating carcinogenicity. Toxicol. Appl. Pharmacol. 1966; 9: 583
   Web of Science ®Google Scholar
• Kerr R., Lefeure A., Lane B. P., Lieber C. S. Liver growth induced by butylated hydroxytoluene (BHT). Clin. Res. 1967; 14: 229
   Google Scholar
• Lane B. P., Lieber C. S. Effects of butylated hydroxytoluene on the ultrastructure of rat hepatocytes. Lab. Invest. 1967; 16: 342
   PubMed Web of Science ®Google Scholar
• Kohn R. R. Effect of antioxidants on life-span of C57BL mice. J. Gerontol 1971; 26: 378
   PubMedGoogle Scholar
• Marino A. A., Mitchell J. T. Lung damage to mice following intraperitoneal injection of butylated hydroxytoluene. Proc. Soc. Exp. Biol. Med. 1972; 140: 122
   PubMed Web of Science ®Google Scholar
• Grantham P. H., Weisburger J. H., Weisburger E. K. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide. Food Cosmet. Toxicol. 1973; 11: 209
   PubMedGoogle Scholar
• Witschi H., Saheb W. Simulation of DNA synthesis in mouse lung following intraperitoneal injection of butylated hydroxytoluene, Proc. Soc. Exp. Biol. Med. 1974; 147: 690
   PubMed Web of Science ®Google Scholar
• Branen A. L. Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene. J. Am. Oil Chem. Soc. 1975; 52: 59
   PubMed Web of Science ®Google Scholar
• Saheb W., Witschi H. Lung growth in mice after a single dose of butylated hydroxytoluene. Toxicol. Appl. Pharmacol. 1975; 33: 309
   PubMed Web of Science ®Google Scholar
• Allen J. R. Long-term antioxidant exposure effects on female primates. Arch. Environ. Health 1976; 31: 47
   PubMed Web of Science ®Google Scholar
• Witschi H., Kacew S., Tsang B. K., Williams D. Biochemical parameters of BHT induced cell growth in mouse lung. Chem. Biol. Interact. 1976; 12: 29
   PubMed Web of Science ®Google Scholar
• Adamson I. Y. R., Bowden D. H., Cote M. G., Witschi H. Lung injury induced by butylated hydroxytoluene: cytodynamic and biochemical studies in mice. Lab. Invest. 1977; 36: 26
   PubMed Web of Science ®Google Scholar
• Berry D. L., DiGiovanni J., Juchau M. R., Bracken W. M., Gleason G. L., Salga R. J. Lack of tumor-promoting ability of certain environmental chemicals in a two-stage mouse skin tu-morigenesis assay. Res. Commun. Chem. Path. Pharmacol. 1978; 20: 101
   PubMedGoogle Scholar
• Evaluation of the Health Aspects of Butylated Hydroxyanisole as a Food Ingredient. National Technical Information Service. Food and Drug Administration, Springfield, Va 1978
   Google Scholar
• Witschi H., Lock A. Toxicity of butylated hydroxytoluene in mouse following oral administration. Toxicology 1978; 9: 137
   PubMed Web of Science ®Google Scholar
• Bioassay of Butylated Hydroxytoluene (BHT) for Possible Carcinogenicity, DHEN Publ. No. (NIH) 79-1706. Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute. U.S. Government Printing Office, Washington, DC 1979
   Google Scholar
• Reddy B. S., Furuya K., Hanson D., DiBello J., Berke B. Effect of dietary butylated hy-droxyanisole on methylazoxymethanol acetate-induced toxicity in mice. Food Chem. Toxicol. 1982; 20: 853
   PubMed Web of Science ®Google Scholar
• Hanig J. P., Yoder P. D., Krop S. Protection with butylated hydroxytoluene and other compounds against intoxication and mortality caused by hexachlorophene. Food Chem. Toxicol. 1984; 22: 185
   PubMed Web of Science ®Google Scholar
• Furukawa K., Maeura Y., Furukawa N. T., Williams G. M. Induction by butylated hydroxytoluene of rat liver γ-glutamyl transpeptidase activity in comparison to expression in carcinogen-induced altered lesions. Chem. Biol. Interact. 1984; 48: 43
   PubMed Web of Science ®Google Scholar
• Dacre J. C., Denz F. A. The metabolism of butylated hydroxyanisole in the rabbit. Biochem. J. 1956; 64: 777
   PubMed Web of Science ®Google Scholar
• Astill B. D., Fassett D. W., Roudabush R. L. The metabolism of phenolic antioxidants. II. The metabolism of butylated hydroxyanisole in the rat. Biochem. J. 1960; 75: 543
   PubMed Web of Science ®Google Scholar
• Dacre J. C. The metabolism of 3,5-di-tert-butyl-4-hydroxytoluene and 3,5-di-tert-butyl-4-hydroxy-benzoic acid in the rabbit. Biochem. J. 1961; 78: 758
   PubMed Web of Science ®Google Scholar
• Astill B. D., Mills J., Fassett D. W., Roudabush R. L., Terhaar C. J. Fate of butylated hydroxyanisole in man and dog. Agric. Food Chem. 1962; 10: 315
   Web of Science ®Google Scholar
• Golder W. S., Ryan A. J., Wright S. E. The urinary excretion of tritiated butylated hydroxyanisole and butylated hydroxytoluene in the rat. J. Pharm. Pharmacol. 1962; 14: 268
   PubMed Web of Science ®Google Scholar
• Ladomery L. G., Ryan A. J., Wright S. E. The urinary excretion of14C-labelled butylated hydroxytoluene by the rat. J. Pharm. Pharmacol. 1963; 15: 771
   PubMed Web of Science ®Google Scholar
• Daniel J. W., Gage J. C. The absorption and excretion of butylated hydroxytoluene (BHT) in the rat. Food Cosmet. Toxicol. 1965; 3: 405
   PubMedGoogle Scholar
• Hathway D. E. Metabolic fate in animals of hindered phenolic antioxidants in relation to their safety evaluation and antioxidant function. Adv. Food Res. 1966; 15: 1
   PubMedGoogle Scholar
• Daniel J. W., Gage J. C., Jones D. I., Stevens M. A. Excretion of butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) by man. Food Cosmet. Toxicol. 1967; 5: 475
   PubMedGoogle Scholar
• Ladomery L. G., Ryan A. J., Wright S. E. The excretion of [14C]butylated hydroxytoluene in the rat. J. Pharm. Pharmacol. 1967; 19: 383
   PubMed Web of Science ®Google Scholar
• Ladomery L. G., Ryan A. J., Wright S. E. The biliary metabolites of butylated hydroxytoluene in the rat. J. Pharm. Pharmacol. 1967; 19: 388
   PubMed Web of Science ®Google Scholar
• Daniel J. W., Gage J. C., Jones D. I. The metabolism of 3,5-di-tert-butyl-4-hydroxytoluene in the rat and man. Biochem. J. 1968; 106: 783
   PubMed Web of Science ®Google Scholar
• Holder G. M., Ryan A. J., Watson T. R., Wiebe L. I. The metabolism of butylated hydroxytoluene, (3,5-di-t-butyl-4-hydroxytoluene) in man. J. Pharm. Pharmacol. 1970; 22: 375
   PubMed Web of Science ®Google Scholar
• Holder G. M., Ryan A. J., Watson T. R., Wiebe L. I. The biliary metabolism of butylated hydroxytoluene (3,5-di-t-butyl-4-hydroxytoluene) and its derivatives in the rat. J. Pharm. Pharmacol. 1970; 22: 832
   PubMed Web of Science ®Google Scholar
• Daniel J. W., Gage J. C. The metabolism of BHT by man. Food Cosmet. Toxicol. 1971; 9: 320
   PubMedGoogle Scholar
• Shaw Y., Chen C. Ring hydroxylation of di-t-butylhydroxytoluene by rat liver microsomal preparation. Biochem. J. 1972; 128: 1285
   PubMed Web of Science ®Google Scholar
• Daniel J. W., Green T., Phillips P. J. Metabolism of the phenolic antioxidant 3,5-di-tert-butyl-4-hydroxyanisole (topanol 354). I. Excretion and tissue distribution in man, rat and dog. Food Cosmet. Toxicol. 1973; 11: 771
   PubMedGoogle Scholar
• Daniel J. W., Green T., Phillips P. J. Metabolism of the phenolic antioxidant 3,5-di-tert-butyl-4-hydroxyanisole (topanol 354). II. Biotransformation in man, rat and dog. Food Cosmet. Toxicol. 1973; 11: 781
   PubMedGoogle Scholar
• Daniel J. W., Green T., Phillips P. J. Metabolism of the phenolic antioxidant 3,5-di-tert-butyl-4-hydroxyanisole (topanol 354). III. The metabolism in rats of the major autoxidation product, 2,6-di-tert-butyl-p-benzoquinone. Food Cosmet. Toxicol. 1973; 11: 793
   PubMedGoogle Scholar
• Chen C., Shaw Y. Cyclic metabolic pathway of a butylated hydroxytoluene by rat liver microsomal fractions. Biochem. J. 1974; 144: 497
   PubMed Web of Science ®Google Scholar
• Speier J. L., Wattenberg L. W. Alterations in microsomal metabolism of benzolalpyrene in mice fed butylated hydroxyanisole. J. Natl. Cancer Inst. 1975; 55: 469
   PubMedGoogle Scholar
• Takahashi O., Hiraga K. 2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone: a hepatic metabolite of butylated hydroxytoluene in rats. Food Cosmet. Toxicol. 1979; 17: 451
   PubMedGoogle Scholar
• Takahashi O., Hiraga K. Excretion of dietary butylated hydroxytoluene by the rat. Toxicol. Lett. 1980; 6: 287
   PubMed Web of Science ®Google Scholar
• Minegishi K., Watanabe M., Yamaha T. Distribution of butylated hydroxyanisole and its conjugates in the tissues of rats. Chem. Pharm. Bull. 1981; 29: 1377
   PubMed Web of Science ®Google Scholar
• Rahimtula A. D., Jernström B., Dock L., Moldeus P. Effects of dietary and in vitro 2(3)-t-butyl-4-hydroxyanisole and other phenols on hepatic enzyme activities in mice. Br. J. Cancer 1982; 45: 935
   PubMed Web of Science ®Google Scholar
• Young-Nam C., Henry S. H. Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res. 1982; 42: 2609
   PubMed Web of Science ®Google Scholar
• Rahimtula A. In vitro metabolism of 3-t-butyl-4-hydroxyanisole and its irreversible binding to proteins. Chem. Biol. Interact. 1983; 45: 125
   PubMed Web of Science ®Google Scholar
• Takahashi O., Hiraga K. The role of 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide) in the metabolism of butylated hydroxytoluene. Food Chem. Toxicol. 1983; 21: 279
   PubMed Web of Science ®Google Scholar
• Matsuo M., Mihara K., Okuno M., Ohdawa H., Miyamoto J. Comparative metabolism of 3,5-di-tert-butyl-4-hydroxytoluene (BHT) in mice and rats. Food Chem. Toxicol. 1984; 22: 345
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J. Natl. Cancer Inst. 1972; 48: 1425
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W. Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole. J. Natl. Cancer Inst. 1973; 50: 1541
   PubMed Web of Science ®Google Scholar
• Ulland B. M., Weisburger J. H., Yamamoto R. S., Weisburger E. K. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-fluorenylacetamide in rats. Food Cosmet. Toxicol. 1973; 11: 199
   PubMedGoogle Scholar
• Wattenberg L. W. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by several sulfur-containing compounds. J. Natl. Cancer Inst. 1974; 52: 1583
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W. Inhibitors of colon carcinogenesis. Cancer 1977; 40: 2432
   PubMed Web of Science ®Google Scholar
• Slaga T. J., Bracke W. M. The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase. Cancer Res. 1977; 37: 1631
   PubMed Web of Science ®Google Scholar
• Weisburger E. K., Evarts R. P., Wenk M. L. Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane. Food Cosmet. Toxicol. 1977; 15: 139
   PubMedGoogle Scholar
• Wattenberg L. W. Inhibition of chemical carcinogenesis. J. Natl. Cancer Inst. 1978; 60: 11
   PubMed Web of Science ®Google Scholar
• Clapp N. K., Tyndall R. L., Satterfield L. C., Klima W. C., Bowles N. D. Selective sex-related modification of diethylnitrosamine-induced carcinogenesis in BALB/c mice by concomitant administration of butylated hydroxytoluene. J. Natl. Cancer Inst. 1978; 61: 177
   PubMedGoogle Scholar
• Clapp N. K., Boweles N. D., Satterfield L. C., Klima W. C. Selective protective effect of butylated hydroxytoluene against 1,2-dimethylhydrazine carcinogenesis in BALB/c mice. J. Natl. Cancer Inst 1979; 63: 1081
   PubMedGoogle Scholar
• King M. M., Bailey D. M., Gibson D. D., Pitha J. V., McCay P. B. Incidence and growth of mammary tumors induced by 7,12-dimethylbenz(a) anthracene as related to the dietary content of fat and antioxidant. J. Natl. Cancer Inst. 1979; 63: 657
   PubMedGoogle Scholar
• Wattenberg L. W. Inhibitory effects of butylated hydroxyanisole on methylazoxymethanol acetate-induced neoplasia of the large intestine and on nicotinamide adenine dinucleotide-dependent alcohol dehydrogenase activity in mice. J. Natl. Cancer Inst. 1979; 63: 219
   PubMedGoogle Scholar
• Wattenberg L. W., Jerina D. M., Lam L. K. T., Yagi H. Neoplastic effects of oral administration oftrans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and their inhibition by butylated hydroxyanisole. J. Natl. Cancer Inst 1979; 62: 1103
   PubMedGoogle Scholar
• Wattenberg L. W. Inhibitors of chemical carcinogens. J. Environ. Pathol. Toxicol. 1980; 3: 35
   PubMed Web of Science ®Google Scholar
• Cohen B. I., Raicht R. F. Plant sterols: protective role in chemical carcinogenesis. Inhibition of Tumor Induction and Development, M. S. Zedeck, M. Lipkin. Plenum Press, New York 1981; 189
   Google Scholar
• King M. M., McCay P. B., Kosanke S. D. Comparison of the effect of butylated hydroxytoluene on N-nitroso-methylurea and 7,12-dimethylbenz(a]anthracene-induced mammary tumors. Cancer Lett. 1981; 14: 219
   PubMed Web of Science ®Google Scholar
• Kim H. L., Johnes L. P. Protective effects of butylated hydroxyanisole, ethoxyquin and disul-firam on acute pyrrolizidine alkaloid poisonings and mice. Res. Commun. Chem. Pathol. Pharmacol. 1982; 36: 341
   PubMedGoogle Scholar
• Reddy B. S., Hirota N., Katayama S. Effect of dietary sodium ascorbate on 1,2-dimethylhydrazine-or methylnitrosourea-induced colon carcinogenesis in rats. Carcinogenesis 1982; 3: 1097
   PubMed Web of Science ®Google Scholar
• Shklar G. Oral mucosal carcinogenesis in hamsters: inhibition by vitamin E. J. Natl. Cancer Inst 1982; 68: 791
   PubMed Web of Science ®Google Scholar
• Reddy B. S., Maeura Y., Weisburger J. H. Effect of various levels of dietary butylated hydroxyanisole on methylazoxymethanol acetate-induced colon carcinogenesis in CF1 mice. J. Natl. Cancer Inst. 1983; 71: 1299
   PubMedGoogle Scholar
• Williams G. M., Maeura Y., Weisburger J. H. Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytoluene. Cancer Lett. 1983; 19: 55
   PubMed Web of Science ®Google Scholar
• Reddy B. S., Maeura Y. Dose-response studies of the effect of dietary butylated hydroxyanisole on colon carcinogenesis induced by methylazoxymethanol acetate in female CFI mice. J. Natl. Cancer Inst. 1984; 72: 1181
   PubMedGoogle Scholar
• Witschi H., Williamson D., Lock S. Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene. J. Natl. Cancer Inst. 1977; 58: 301
   PubMed Web of Science ®Google Scholar
• Witschi H., Lock S. Enhancement of adenoma formation in mouse lung by butylated hydroxytoluene. Toxicol. Appl. Pharmacol. 1979; 50: 391
   PubMed Web of Science ®Google Scholar
• Cook M. G., McNamara P. Effect of dietary vitamin E on dimethylhydrazine-induced colonic tumors in mice. Cancer Res. 1980; 40: 1329
   PubMed Web of Science ®Google Scholar
• Witschi H. Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology 1981; 21: 95
   PubMed Web of Science ®Google Scholar
• Djurhuns R., Lillehang J. R. Butylated hydroxytoluene: tumor-promoting activities in anin vitro two-stage carcinogenesis assay. Bull. Environ. Contam. Toxicol. 1982; 29: 115
   PubMed Web of Science ®Google Scholar
• Toth B., Patil K. Enhancing effect of vitamin E on murine intestinal tumorigenesis by 1,2-dimethylhydrazine dihydrochloride. J. Natl. Cancer Inst. 1983; 70: 1107
   PubMed Web of Science ®Google Scholar
• Maeura Y., Weisburger J. H., Williams G. M. Dose-dependent reduction of N-2-fluorenyla-cetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. Cancer Res. 1984; 44: 1604
   PubMed Web of Science ®Google Scholar
• Sugimura T., Fujiki H., Mori M., Nakayasu M., Terada M., Umezawa K., Moore R. E. Teleocidin: new naturally occurring tumor promoter. Carcinogenesis, a Comprehensive Survey, E. Hecker, N. E. Fusenig, W. Kunz, F. Marks, H. W. Thielmann. Raven Press, New York 1982; Vol. 7: 69
   Google Scholar
• Sugimura T. Mutagens, carcinogens and tumor promoters in our daily food. Cancer 1982; 49: 1970
   PubMed Web of Science ®Google Scholar
• Ames B. N. Dietary carcinogens and anticarcinogens; oxygen radicals and degenerative diseases. Science 1983; 221: 1256
   PubMed Web of Science ®Google Scholar
• Sugimura T., Sato S. Mutagens-carcinogens in foods. Cancer Res. 1983; 43: 2415, Suppl
   PubMed Web of Science ®Google Scholar
• Berenblum I., Shubik P. A. A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br. J. Cancer 1947; 1: 383
   PubMed Web of Science ®Google Scholar
• Boutwell R. K. Some biological aspects of skin carcinogenesis. Proc. Exp. Tumor Res. 1964; 4: 207
   PubMed Web of Science ®Google Scholar
• Weinstein I. B., Troll W. National cancer institute workshop on tumor promotion and cofac-(ors in carcinogenesis. Cancer Res. 1977; 37: 3461
   Web of Science ®Google Scholar
• Hecker E. Structure activity relationships in diterpene esters irritant and cocarcinogenic to mouse skin. Carcinogenesis, Mechanism of Tumor Promotion and Cocarcinogenesis, T. J. Slaga, A. Sivak, R. K. Boutwell. Raven Press, New York 1978; Vol. 2: 11
   Google Scholar
• Fujiki H., Mori M., Nakayasu M., Terada M., Sugimura T., Moore R. E. Indole alkaloids; dihydroteleocidin B, teleocidin and lyngbyatoxin A, as a new class of tumor promoters. Proc. Natl. Acad. Sci. U.S.A. 1980; 78: 3872
   Web of Science ®Google Scholar
• Fujiki H., Suganuma M., Nakayasu M., Hoshino H., Moore R. E., Sugimura T. The third class of new tumor promoters, polyacetates (debromoaplysiatoxin and aplysiatoxin), can differentiate biological actions relevant to tumor promoters. Gann 1982; 73: 495
   PubMedGoogle Scholar
• Sugimura T. Potent tumor promoters other than phorbol ester and their significance. Gann 1982; 73: 499
   PubMedGoogle Scholar
• Hicks R. M., Wakefield J., Chowaniec J. Evaluation of a new model to detect bladder carcinogens or co-carcinogens: results obtained with saccharin, cyclamate and cyclophosphamide. Chem. Biol. Interact. 1975; 11: 225
   PubMed Web of Science ®Google Scholar
• Cohen S. M., Arai M., Jacobs J. B., Friedell G. H. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res. 1979; 39: 1207
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Hagiwara A., Shibata M., Imaida K., Tatematsu M., Ito N. Dose-response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl) nitrosamine. J. Natl. Cancer Inst. 1980; 65: 1005
   PubMed Web of Science ®Google Scholar
• Fukushima S., Friedell G. H., Jacobs J. B., Cohen S. M. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res. 1981; 41: 3100
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Fukushima S., Hagiwara A., Tamano S., Ito N. Organ-specific promoting effects of phenobarbital sodium and sodium saccharin in the induction of liver and urinary bladder tumors in male F344 rats. J. Natl. Cancer Inst. 1982; 68: 497
   PubMedGoogle Scholar
• Ito N., Fukushima S., Shirai T., Nakanishi K., Hasegawa R., Imaida K. Modifying factors in urinary bladder carcinogenesis. Environ. Health Perspect. 1983; 49: 217
   PubMed Web of Science ®Google Scholar
• Ito N., Fukushima S., Shirai T., Nakanishi K. Effects of promoters on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in the rat. Environ. Health Perspect. 1983; 50: 61
   PubMed Web of Science ®Google Scholar
• Fukushima S., Hagiwara A., Ogiso T., Shibata M., Ito N. Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl) amine. Food Chem. Toxicol. 1983; 21: 59
   PubMed Web of Science ®Google Scholar
• Peraino C., Fry R. J. M., Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 1971; 31: 1506
   PubMed Web of Science ®Google Scholar
• Peraino C., Fry R. J. M., Staffeldt E., Christopher J. P. Enhancing effects of phenobarbitone and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Food Cosmet. Toxicol. 1977; 15: 93
   PubMedGoogle Scholar
• Kitagawa T., Pitot H. C., Miller E. C., Miller J. A. Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methy-N, N-dimethyl-4-aminoazobenzene in the rat. Cancer Res. 1979; 39: 112
   PubMed Web of Science ®Google Scholar
• Ito N., Tatematsu M., Imaida K., Hasegawa R., Murasaki G. Effects of various promoters on the induction of hyperplastic nodules in rat liver. Gann 1980; 71: 415
   PubMedGoogle Scholar
• Takano T., Tatematsu M., Hasegawa R., Imaida K., Ito N. Dose-response relationship for the promoting effect of phenobarbital on the induction of liver hyperplastic nodules in rats exposed to 2-fluorenylacetamide and carbon tetrachloride. Gann 1980; 71: 580
   PubMedGoogle Scholar
• Ito N., Tsuda H., Hasegawa R., Imaida K. Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver. Environ. Health Perspect. 1983; 50: 131
   PubMed Web of Science ®Google Scholar
• Tsuda H., Fukushima S., Imaida K., Kurata Y., Ito N. Organ-specific promoting effect of phenobarbital and saccharin in induction of thyroid, liver, and urinary bladder tumors in rats after initiation with N-nitrosomethylurea. Cancer Res. 1983; 43: 3292
   PubMed Web of Science ®Google Scholar
• Hiasa Y., Ohshima M., Kitahori Y., Konishi N., Fujita T., Yuasa T. β-Cyclodextrin: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine. J. Natl. Cancer Inst. 1983; 69: 963
   Google Scholar
• Shirai T., Ohshima M., Masuda A., Tamano S., Ito N. Promotion of 2-(ethylnitrosamine) ethanol-induced renal carcinogenesis in rats by nephrotoxic compounds: positive responses with folic acid, basic lead acetate, and N-(3,5-dichlorophenyl) succinimide but not with 2,3-dibromo-1-propanol phosphate. J. Natl. Cancer Inst. 1984; 72: 477
   PubMedGoogle Scholar
• Hiasa Y., Kitahori Y., Konishi N., Enoki N., Shimoyama T., Miyashiro A. Trisodium nitrilotriacetate monohydrate: promoting effects on the developing of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine. J. Natl. Cancer Inst. 1984; 72: 483
   PubMedGoogle Scholar
• Ito N., Hagiwara A., Shibata M., Ogiso T., Fukushima S. Induction of squamous cell carcinoma in the forestomach of F344 rats treated with butylated hydroxyanisole. Gann 1982; 73: 332
   PubMedGoogle Scholar
• Ito N., Fukushima S., Hagiwara A., Shibata M., Ogiso T. Carcinogenicity of butylated hydroxyanisole in F344 rats. J. Natl. Cancer Inst. 1983; 70: 343
   PubMed Web of Science ®Google Scholar
• Ishiwata H., unpublished data
   Google Scholar
• Ishitani T., Hirata T., Takai G., Kimura S. Volatilization and decomposition of antioxidants by heating. Nippon Shokuhin Kogyo Gakkai-Shi 1976; 23: 244
   Google Scholar
• Ishiwata H., Kaneko K., Kato S., Tanimura A. Decrease of butylated hydroxyanisole added in the diet for a carcinogenicity test in rats and mice. Bull. Environ. Contam. Toxicol. 1982; 28: 379
   PubMed Web of Science ®Google Scholar
• Ito N., Fukushima S., Imaida K., Sakata T., Masui T. Induction of papilloma in the forestomach of hamsters by butylated hydroxyanisole. Gann 1983; 74: 459
   PubMedGoogle Scholar
• Ito N., Hirose M., Kurata Y., Ikawa E., Mera Y., Fukushima S. Induction of forestomach hyperplasia by crude butylated hydroxyanisole, a mixture of 3-tert and-2-tertisomers in Syrian golden hamsters is due to 3-tert-butylated hydroxyanisole. Gann 1984; 75: 471
   PubMedGoogle Scholar
• Hirose M., Shibata M., Hagiwara A., Imaida K., Ito N. Chronic toxicity of butylated hydroxytoluene in Wistar rats. Food Cosmet. Toxicol. 1981; 19: 147
   PubMedGoogle Scholar
• Shirai T., Hagiwara A., Kurata Y., Shibata M., Fukushima S., Ito N. Lack of carcinogenicity of butylated hydroxytoluene on long-term administration to B6C3F1 mice. Food Cosmet. Toxicol. 1982; 20: 861
   Google Scholar
• Shirai T., Fukushima S., Ohshima M., Masuda A., Ito N. Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. J. Natl. Cancer Inst. 1984; 72: 1189
   PubMedGoogle Scholar
• Hirayama T. Epidemiology of stomach cancer. Gann Monogr. 1971; 11: 3
   Google Scholar
• Shirai T., Imaida K., Fukushima S., Hasegawa R., Tatematsu M., Ito N. Effect of NaCl, Tween 60 and a low dose of N'-ethyl-N'-nitro-N-nitrosoguanidine on gastric carcinogenesis of rat given a single dose of N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 1982; 3: 1419
   PubMed Web of Science ®Google Scholar
• Takahashi M., Kokubo T., Furukawa F., Kurokawa Y., Tatematsu M., Hayashi Y. Effect of high salt diet on rat gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine. Gann 1983; 74: 28
   PubMedGoogle Scholar
• Tatematsu M., Takahashi M., Fukushima S., Hananouchi M., Shirai T. Effects on rat of sodium chloride on experimental gastric cancer induced by N-methyl-N'-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J. Natl. Cancer Inst. 1975; 55: 101
   PubMedGoogle Scholar
• Tatematsu M., Takahashi M., Hananouchi M., Shirai T., Hirose M., Fukushima S., Ito N. Protective effect of mucin on experimental gastric cancer induced by N-methyl-N'-nitro-N-nitro-soguanidine plus sodium chloride in rat. Gann 1976; 67: 223
   PubMedGoogle Scholar
• Takahashi M., Kokubo T., Furukawa F., Kurokawa Y., Hayashi Y. Promoting effects of sodium chloride, saccharin and others on experimental gastric carcinogenesis in the rat. Proc. Jpn. Cancer Assoc. 1983; 42: 87
   Google Scholar
• Imaida K., Fukushima S., Shirai T., Ohtani M., Nakanishi K., Ito N. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and the inhibition of γ-glutamyl transpeptidase-positive foci development in the liver of rats. Carcinogenesis 1983; 4: 895
   PubMed Web of Science ®Google Scholar
• Ito N., Tatematsu M., Nakanishi K., Hasegawa R., Takano T., Imaida K., Ogiso T. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. Gann 1980; 71: 832
   PubMedGoogle Scholar
• Tamano S., Tsuda H., Tatematsu M., Hasegawa R., Imaida K., Ito N. Induction of γ-glutamyl transpeptidase positive foci in rat liver by pyrolysis products of amino acids. Gann 1981; 77: 747
   Google Scholar
• Cameron R. G., Imaida K., Tsuda H., Ito N. Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res. 1982; 42: 2426
   PubMed Web of Science ®Google Scholar
• Ito N., Tsuda H., Hasegawa R., Imaida K. Sequential observation of pathomorphologic alterations in preneoplastic lesions during the promoting stage of hepatocarcinogenesis and the development of short-term test system for hepatopromoters and hepatocarcinogens. Toxicol. Pathol. 1982; 10: 37
   PubMedGoogle Scholar
• Tamano S., Tsuda H., Fukushima S., Masui T., Hosoda K., Ito N. Dose and sex dependent effects of 2-acetylaminofluorene, 3′-methyl-4-dimethylaminoazobenzene and DL-ethionine in induction of γ-glutamyl transpeptidase-positive liver cell foci in rats. Cancer Lett. 1983; 20: 313
   PubMed Web of Science ®Google Scholar
• Tatematsu M., Hasegawa R., Imaida K., Tsuda H., Ito N. Survey of various chemicals for initiating and promoting activities in a short-termin vivo system based on generation of hyperplastic liver nodules in rats. Carcinogenesis 1983; 4: 381
   PubMed Web of Science ®Google Scholar
• Ito N., Tsuda H., Sakata T., Haasegawa R., Tamano S. Inhibitory effect of butylated hydroxyanisole and ethoxyquin on the induction of neoplastic lesions in rat liver after an initial treatment with N-ethyl-N-hydroxyethylnitrosamine. Gann 1983; 74: 466
   PubMedGoogle Scholar
• Tsuda H., Sakata T., Tamano S., Okumura M., Ito N. Sequential observations on the appearance of neoplastic lesions in the liver and kidney after treatment with N-ethyl-N-hydroxyethyl-nitrosamine followed by partial hepatectomy and unilateral nephrectomy. Carcinogenesis 1983; 4: 523
   PubMed Web of Science ®Google Scholar
• Farber E. The pathology of experimental liver cell cancer. Liver Cell Cancer, D. A. Linsell, G. P. Warwich. Elsevier, Amsterdam 1976; 243
   Google Scholar
• Bannasch P., Mayer D., Krech R. Neoplastische und präneoplastisch Veränderungen bei Ratten nach einmaliger oraler Applikation von N-nitrosomorpholin. J. Cancer Res. Clin. Oncol. 1979; 94: 233
   PubMedGoogle Scholar
• Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, Histologic typing of liver tumors of the rat. J. Natl. Cancer Inst. 1980; 64: 179
   Google Scholar
• Fukushima S., Imaida K., Sakata T., Okumura T., Shibata M., Ito N. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res. 1983; 43: 4454
   PubMed Web of Science ®Google Scholar
• Slaga T. J., Bowden J. D., Scribner J. D., Boutwell R. K. Dose-response studies on the ability of 7,12-dimethylbenz(alpha) anthracene and benz(alpha) anthracene to initiate skin tumors. J. Natl. Cancer Inst. 1974; 53: 1337
   PubMed Web of Science ®Google Scholar
• Tsuda H., Lee G., Farber E. Induction of resistant hepatocytes as a new principle for a possible short-termin vivo test for carcinogens. Cancer Res. 1980; 40: 1157
   PubMed Web of Science ®Google Scholar
• Fukushima S., Murasaki G., Hirose M., Nakanishi K., Hasegawa R., Ito N. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in rats. Acta Pathol. Jpn. 1982; 32: 243
   PubMedGoogle Scholar
• Ito N., Matayoshi K., Arai M., Yoshioka Y., Kamanoto Y., Makiura S., Sugihara S. Effect of various factors on induction of urinary bladder tumors in animals by N-butyl-N-(4-hydrox-ybutyl) nitrosamine. Gann 1973; 64: 151
   PubMedGoogle Scholar
• Ito N., Hiasa Y., Tamai A., Okajima E., Kitamura H. Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann 1969; 60: 401
   PubMedGoogle Scholar
• Fukushima S., Kurata Y., Shibata M., Ikawa E., Ito N. Promotion by ascorbic acid, sodium erythorbate, and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybu-tyl)nitrosamine. Cancer Lett. 1984; 23: 29
   PubMed Web of Science ®Google Scholar
• Fukushima S., Kurata Y., Shibata M., Ikawa E., Ito N. Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats. Gann 1983; 74: 625
   PubMedGoogle Scholar
• Masui T., Imaida K., Fukushima S., Shirai T., Hirose K., Ito N. Organ specificity of promotion effects by BHA, BHT and ascorbate in MNU initiated F344 rats, Froc. Jpn. Cancer Assoc. 1983; 42: 85
   Google Scholar
• IARC Monogr. On Evaluation of Carcinogenic Risk of Chemicals to Man. International Agency for Research on Cancer, LyonFrance 1978; Vol. 17
   Google Scholar
• Tsuda H., Sakata T., Shirai T., Kurata Y., Tamano S., Ito N. Modification of N-methyl-N-nitrosourea initiated carcinogenesis in the rat by subsequent treatment with antioxidants, pheno-barbital and ethinyl estradiol. Cancer Lett. 1984; 24: 19
   PubMed Web of Science ®Google Scholar
• Ishidate M., Odashima S. Chromosome tests with 134 compounds on Chinese hamster cellsin vitro—a screening for chemical carcinogens. Mutat. Res. 1977; 48: 337
   PubMed Web of Science ®Google Scholar
• Joner E. Butylhydroxyanisole (BHA), butylhydroxytoluene (BHT) and ethoxyquin (EMQ) tested for mutagenicity. Acta Vet. Scand. 1977; 18: 187
   PubMed Web of Science ®Google Scholar
• Annual Report of Cancer Research. National Cancer Center. Ministry of Health and Welfare of Japan, Tokyo 1979; 1111
   Google Scholar
• Batzinger B. P., Ou S. Y. L., Bueding E. Antimutagenic effects of 2(3)-tert-butylhydroxyani-sole and of microbial agents. Cancer Res. 1978; 38: 4476
   Web of Science ®Google Scholar
• Cumming R. B., Walton M. F. Modification of the acute toxicity of mutagenic and carcinogenic chemicals in the mouse by prefeeding with antioxidants. Food Cosmet. Toxicol 1973; 11: 547
   PubMedGoogle Scholar
• Shelef L. A., Chin B. Effect of phenolic antioxidants on the mutagenicity of aflatoxin B2. Appl. Environ. Microbiol. 1980; 40: 1039
   PubMed Web of Science ®Google Scholar
• Telford I. R., Woodruff C. S., Linford R. H. Fetal resorption in the rat as influenced by certain antioxidants. Am. J. Anat. 1962; 110: 29
   PubMedGoogle Scholar
• Cleggy D. J. Absence of teratogenic effect of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) in rats and mice. Food Cosmet. Toxicol. 1965; 3: 387
   PubMedGoogle Scholar
• Hansen E., Meyer O. A study of the teratogenicity of butylated hydroxyanisole on rabbits. Toxicology 1978; 10: 195
   PubMed Web of Science ®Google Scholar
• Vorhees C. V., Butcher R. E., Brunner R. L., Wootten V., Sabotka T. J. Developmental neurobehavioral toxicity of butylated hydroxyanisole (BHA) in rats. Neurobehav. Toxicol. Teratol 1981; 3: 321
   PubMedGoogle Scholar
• Brown W. D., Johnson A. R., O'Halloran M. W. The effect of the level of dietary fat on the toxicity of phenolic antioxidants, Ausr. J. Exp. Biol. 1959; 37: 533
   Google Scholar
• Creaven P. J., Davies W. H., Williams R. T. The effect of butylated hydroxytoluene, butylated hydroxyanisole and octyl gallate upon liver weight and biphenyl-4-hydroxylase activity in the rat. J. Pharm. Pharmacol. 1966; 18: 485
   PubMed Web of Science ®Google Scholar
• Martin A. D., Gilbert D. Enzyme changes accompanying liver enlargement in rats treated with 3-tert-butyl-4-hydroxyanisole. Biochem. J. 1968; 106: 22
   Web of Science ®Google Scholar
• Lam L. K. T., Wattenberg L. W. Effects of butylated hydroxyanisole on the metabolism of benzo[a]pyrene by mouse liver microsomes. J. Natl. Cancer Inst. 1979; 58: 413
   Google Scholar
• Miranda C. L., Read R. L., Cheeke P. R., Buhler D. R. Protective effects of butylated hydroxyanisole against the acute toxicity of monocrotaline in mice. Toxicol. Appl. Pharmacol. 1981; 59: 424
   PubMed Web of Science ®Google Scholar
• Imaida K., Fukushima S., Shirai T., Masuda A., Hagiwara A., Ito N. Sequential analysis of BHA induced tumor development in F344 rats, Syrian golden hamsters and B6C3F1 mice. Proc. Jpn. Cancer Assoc. 1983; 42: 28
   Google Scholar
• Lok E., Iverson F., Nera E. A., Clayson D. B. Studies on Effect of Butylated Hydroxyanisole (BHA) on Cell Proliferation in Rat Forestomach. Joint FAO/WHO Expert Committee on Food Additives. World Health Organization, Geneva 1983
   Google Scholar
• Yokoro K. Carcinogenicity test of butylated hydroxyanisole. Annual Report of the Cancer Research. Ministry of Health and Welfare, Tokyo 1981; 1013
   Google Scholar
• Assessment of evidence for carcinogenicity from studies in experimental animals. IARC Monogr. on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. International Agency for Research on Cancer, Lyon 1982; 12, Suppl. 4
   Google Scholar
• Olsen P., Bille N., Meyer O. Hepatocellular neoplasms in rats induced by butylated hydroxytoluene (BHT). Acta Pharmacol. Toxicol. 1983; 53: 433
   PubMedGoogle Scholar
• Wattenberg L. W. The role of the portal of entry in inhibition of tumorigenesis. Progress in Experimental Tumor Research, F. Homburger. S. Karger, Basel 1971; Vol. 14: 89
   Google Scholar
• Wattenberg L. W. Inhibition of chemical carcinogenesis by antioxidants and some additional compounds. Fundamentals in Cancer Prevention, P. N. Magee, S. Takayama, T. Sugimura, T. Matsushima. University of Tokyo Press, Tokyo 1976; 153
   Google Scholar
• Wattenberg L. W. Inhibitors of chemical carcinogenesis. Advances in Cancer Research, G. Klein, S. Weinhouse. Academic Press, New York 1978; Vol. 26: 197
   Google Scholar
• Richardson H. L., Stier A. R., Borsoo-Nachtenbel E. Liver tumor inhibition and adrenal histological responses in rats to which 3′-methyl-4-dimethylaminoazobenzene and 20-methylcholan-threne were simultaneously administered. Cancer Res. 1952; 12: 356
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A., Brown R. R., MacDonald J. On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazodyes and 2-acetylaminofluor-ene. Cancer Res. 1958; 18: 469
   PubMed Web of Science ®Google Scholar
• Marugami M., Ito N., Konishi Y., Hiasa Y., Farber E. Influence of 3-methylcholanthrene on liver carcinogenesis in rats ingesting DL-ethionin, 3′-methyl-4-dimethylaminoazobenzene and N-2-fluorenylacetamide. Cancer Res. 1967; 27: 2011
   PubMed Web of Science ®Google Scholar
• Makiura S., Aoe H., Sugihara S., Hirao K., Arai M., Ito N. Inhibitory effect of polychlor-inated biphenyls on liver tumorigenesis in rats treated with 3′-methyl-4-dimethylaminoazobenzene, N-2-fluorenylacetamide, and diethylnitrosamine. J. Natl. Cancer Inst. 1974; 53: 1253
   PubMedGoogle Scholar
• Speier J. L., Wattenberg L. W. Alterations in microsomal metabolism of benzo[a]pyrene in mice fed butylated hydroxyanisole. J. Natl. Cancer Inst. 1975; 55: 469
   PubMedGoogle Scholar
• Benson A. M., Batzinger R. P., Ou S. Y.-L., Bueding E., Cha Y.-N., Talalay P. Elevation of hepatic glutathione S-transferase activities and protection against metabolites of benzo[a]pyrene by dietary antioxidants. Cancer Res. 1978; 38: 4486
   PubMed Web of Science ®Google Scholar
• Cha Y.-N., Martz F., Bueding E. Enhancement of liver microsome epoxide hydratase activity in rodents by treatment with 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res. 1978; 38: 4496
   PubMed Web of Science ®Google Scholar
• Kahi R., Wulff U. Induction of rat hepatic epoxide hydratase by dietary antioxidants. Toxicol. Appl. Pharmacol. 1978; 47: 217
   Web of Science ®Google Scholar
• Benson A. M., Cha Y.-N., Bueding E., Heine H. S., Talalay P. Evaluation of extrahepatic glutathione S-transferase and epoxide hydratase activities by 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res. 1979; 39: 2971
   PubMed Web of Science ®Google Scholar
• Cha Y.-N., Heine H. S. Comparative effects of dietary administration of 2(3)-tert-4-hydroxy-anisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res. 1982; 42: 2609
   PubMed Web of Science ®Google Scholar
• Sparnins V. L., Venegas P. L., Wattenberg L. W. Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. J. Natl. Cancer Inst. 1982; 68: 493
   PubMed Web of Science ®Google Scholar
• Narisawa T., Magandia N. E., Weisburger J. H., Wynder E. L. Promoting effects of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J. Natl. Cancer Inst. 1974; 53: 1093
   PubMedGoogle Scholar
• Hirose M., Shirai T., Tsuda H., Fukushima S., Ogiso T., Ito N. Effect of phenobarbital, polychlorinated biphenyl and sodium saccharin on hepatic and renal carcinogenesis in unilaterally nephrectomized rats given N-ethyl-N-hydroxyethylnitrosamine orally. Carcinogenesis 1981; 2: 1299
   PubMed Web of Science ®Google Scholar
• Hiasa Y., Kitahori Y., Ohshima M., Fujita T., Yuasa T., Konishi N., Miyashiro A. Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. Carcinogenesis 1982; 3: 1187
   PubMed Web of Science ®Google Scholar
• Hiasa Y., Kitahori Y., Enoki N., Konishi M., Shinoyama T. 4,4′-Diaminodiphenylmethane: promoting effect on development of thyroid tumors in rats treated with N-bis(2-hydroxypro-pyl)nitrosamine. J. Natl. Cancer Inst. 1984; 72: 471
   PubMedGoogle Scholar
• Fukushima S., Hirose M., Hagiwara A., Hasegawa R., Ito N. Inhibitory effect of 4,4′-diaminodiphenylmethane on liver, kidney and bladder carcinogenesis in rats ingesting N-ethyl-N-hydroxyethylnitrosamine or N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 1981; 2: 1033
   PubMed Web of Science ®Google Scholar
• Søndergaaed D., Olsen P. The effect of butylated hydroxytoluene (BHT) on the rat thyroid. Toxicol. Lett. 1982; 10: 239
   PubMed Web of Science ®Google Scholar